Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (791-800 of 1,482) with videos related to

Pageof 149
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|January 13, 2019
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid LeukemiaAbhishek Maiti, Kiran Naqvi, Tapan M Kadia, et al.
Blood Transfusion = Trasfusione Del Sangue|May 27, 2025
The Red Blood Cell-Improving Transfusions for Chronically Transfused Recipients (RBC-IMPACT) study: protocol description of an international multi-site observational clinical studyMatthew S Karafin, Shannon Kelly, Kathleen M Chapman, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2014
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemiaAlfonso Quintás-Cardama, Naval Daver, Hawk Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemiaC Cameron Yin, Nitin Jain, Meenakshi Mehrotra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Variation of mechanical properties and quantitative proteomics of VSMC along the arterial treeCarla Luana Dinardo, Gabriela Venturini, Enhua H Zhou, et al.
Journal of Hematology & Oncology|January 5, 2019
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experienceKamal Chamoun, Hagop Kantarjian, Rami Atallah, et al.
Pediatric Cardiology|May 21, 2015
Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter ExperienceC Huie Lin, Sanyukta Desai, Ramzi Nicolas, et al.
Plos One|June 13, 2015
Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional EvaluationGiulia Maria Camerino, Jean-François Desaphy, Michela De Bellis, et al.
Leukemia|March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Cancer|September 23, 2016
Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemiaFarhad Ravandi, Jeffrey Jorgensen, Gautam Borthakur, et al.
Pageof 149

Showing results (791-800 of 1,482) with videos related to

Sort By:
Pageof 149
Clinical Lymphoma, Myeloma & Leukemia|January 13, 2019
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid LeukemiaAbhishek Maiti, Kiran Naqvi, Tapan M Kadia, et al.
Blood Transfusion = Trasfusione Del Sangue|May 27, 2025
The Red Blood Cell-Improving Transfusions for Chronically Transfused Recipients (RBC-IMPACT) study: protocol description of an international multi-site observational clinical studyMatthew S Karafin, Shannon Kelly, Kathleen M Chapman, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2014
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemiaAlfonso Quintás-Cardama, Naval Daver, Hawk Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemiaC Cameron Yin, Nitin Jain, Meenakshi Mehrotra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Variation of mechanical properties and quantitative proteomics of VSMC along the arterial treeCarla Luana Dinardo, Gabriela Venturini, Enhua H Zhou, et al.
Journal of Hematology & Oncology|January 5, 2019
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experienceKamal Chamoun, Hagop Kantarjian, Rami Atallah, et al.
Pediatric Cardiology|May 21, 2015
Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter ExperienceC Huie Lin, Sanyukta Desai, Ramzi Nicolas, et al.
Plos One|June 13, 2015
Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional EvaluationGiulia Maria Camerino, Jean-François Desaphy, Michela De Bellis, et al.
Leukemia|March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Cancer|September 23, 2016
Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemiaFarhad Ravandi, Jeffrey Jorgensen, Gautam Borthakur, et al.
Pageof 149